Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hydrocortisone (solu-cortef) (1 trial)
prednisone (meticorten) (1 trial)
pomalidomide (pomalyst) (1 trial)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Pneumonia (Phase 3)
Trials (2 total)
Trial APIs (3 total)